OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 23 citing articles:

Nanotechnology and nano-sized tools: Newer approaches to circumvent oncolytic adenovirus limitations
Maryam Mashhadi Abolghasem Shirazi, Tayebeh Azam Saedi, Zahra Samadi Moghaddam, et al.
Pharmacology & Therapeutics (2024) Vol. 256, pp. 108611-108611
Closed Access | Times Cited: 6

Cancer biotherapy: review and prospect
Qi Liu, Hu Ma
Clinical and Experimental Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 5

Expression of some circulating microRNAs as predictive biomarkers for prognosis and treatment response in glioblastoma
Elham Ahmed, Marwa Adel Ahmed, May Ahmed Shawki, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access

Combination therapy with immune checkpoint inhibitors in colorectal cancer: Challenges, resistance mechanisms, and the role of microbiota
Ali Rahimi, Zeinab Baghernejadan, Ali Hazrati, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 186, pp. 118014-118014
Closed Access

Extracellular matrix re-normalization to improve cold tumor penetration by oncolytic viruses
Geofrey F. Soko, Benson Kiprono Kosgei, Stephene S. Meena, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access

Metformin as an immunomodulatory agent in enhancing head and neck squamous cell carcinoma therapies
Wenting Li, Naiming Liu, Mingwei Chen, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025) Vol. 1880, Iss. 2, pp. 189262-189262
Closed Access

ISG15 depletion enhances oHSV-1 replication and antitumor efficacy in oral squamous cell carcinoma
Manman Qiu, Rongrong Wei, Qicheng Zhang, et al.
Virology (2025), pp. 110504-110504
Closed Access

Advances in the Drug Development and Quality Evaluation Principles of Oncolytic Herpes Simplex Virus
Basma Eid Abdullah Ghorab, Tongtan Liu, Min Ying, et al.
Viruses (2025) Vol. 17, Iss. 4, pp. 581-581
Open Access

Mechanisms of Resistance and Therapeutic Perspectives in Immunotherapy for Advanced Head and Neck Cancers
Andrew Meci, Neerav Goyal, Guy Slonimsky
Cancers (2024) Vol. 16, Iss. 4, pp. 703-703
Open Access | Times Cited: 3

Immunogenic cell death-based oncolytic virus therapy: a sharp sword of tumor immunotherapy
Jingyu Zhang, Jiahe Chen, Kezhi Lin
European Journal of Pharmacology (2024) Vol. 981, pp. 176913-176913
Open Access | Times Cited: 3

Natural killer cell‐based signature: Prognostic analysis in head and neck squamous cell carcinoma
Zizhao Guo, Yuxia Zhao, Meng Xu, et al.
The Journal of Gene Medicine (2024) Vol. 26, Iss. 2
Closed Access | Times Cited: 2

Macrophage Profiling in Head and Neck Cancer to Improve Patient Prognosis and Assessment of Cancer Cell–Macrophage Interactions Using Three-Dimensional Coculture Models
Nour Mhaidly, Fabrice Journé, Ahmad Najem, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 12813-12813
Open Access | Times Cited: 6

The antitumor effect of oncolytic respiratory syncytial virus via the tumor necrosis factor-alpha induction and ROS-bax-mediated mechanisms
Mehdi Samadi, Talat Mokhtari‐Azad, Ahmad Nejati, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 5

A viral attack on brain tumors: the potential of oncolytic virus therapy
Kasra Mokhtarpour, Milad Akbarzadehmoallemkolaei, Nima Rezaei
Journal of NeuroVirology (2024) Vol. 30, Iss. 3, pp. 229-250
Closed Access | Times Cited: 1

Localized intratumoral delivery of immunomodulators for oral cancer and oral potentially malignant disorders
Nourhan I Hussein, Andrea H Molina, Gemalene Sunga, et al.
Oral Oncology (2024) Vol. 158, pp. 106986-106986
Closed Access | Times Cited: 1

The implications of oncolytic viruses targeting fibroblasts in enhancing the antitumoural immune response
Ibrahem Al-Obaidi, Ciaran Sandhu, Bilal Javaid Qureshi, et al.
Heliyon (2024) Vol. 10, Iss. 20, pp. e39204-e39204
Open Access | Times Cited: 1

An Engineered Self-biomineralized Oncolytic Adenovirus Induces Effective Antitumor Immunity and Synergizes With Immune Checkpoint Blockade
Shibing Wang, Xue Yang, Ying-Yu Ma, et al.
Cancer Immunology Research (2024) Vol. 12, Iss. 11, pp. 1640-1654
Open Access

RNA Modifications as a Therapeutic Target in Gastrointestinal Cancer: Exploring Emerging Opportunities
Haiyun Shang, Xiaoting Zhang, Hao Su, et al.
Interdisciplinary cancer research (2024)
Closed Access

Salivary biomarkers: a promising approach for predicting immunotherapy response in head and neck cancers
Armin Nejat Dehkordi, Moein Maddahi, Parinaz Vafa, et al.
Clinical & Translational Oncology (2024)
Closed Access

Neoadjuvant immunotherapy and oncolytic virotherapy in HPV positive and HPV negative skin cancer: A comprehensive review
Ali Salimi Asl, Mohsen Davari, Atousa Ghorbani, et al.
International Immunopharmacology (2024) Vol. 146, pp. 113790-113790
Closed Access

Gene Therapy for Cancer
Seiji Kuroda, Makoto Sukegawa
Nihon Ika Daigaku Igakkai Zasshi (2023) Vol. 19, Iss. 3, pp. 235-241
Open Access

Page 1

Scroll to top